USPTO Biotech/Chemical Partnership (BCP) Meetings

Sep 24, 2018, 18:17 PM by AIPLA Admin

​USPTO September 24, 2018 BCP meeting presentation by Abraham Amjad, SPE and Shubo (Joe) Zhou, SPE TC1600 on "Requirements for Information Under 37 CFR 1.105 and Responses to Said Requirements."

Biotechnology, Chemical and Pharmaceutical (BCP) Partnership Meeting
September 24, 2018
United States Patent and Trademark Office
USPTO Main Campus (Alexandria), Madison Auditorium

BCP Sep 2018 37 CFR 1.105 Slides

10-10:10 a.m.  ET Welcoming and Opening Remarks

• Gary Jones, Director TC1600, USPTO
• Daniel Sullivan, Director, TC1600, USPTO
• Andrew Wang. Director, TC1600, USPTO

10:10- 11 a.m. ET Obviousness of Biologics: Identifying the Biggest Challenges

• Carla Mouta-Bellum, Partner, Arrigo, Lee, Guttman & Mouta-Bellum LLP

11-11:50 a.m. ET Exemplary Obviousness Rationales Suggested in KSR

• Lora Driscoll, QAS, TC1600, USPTO

11:50-12:50 p.m. ET BREAK/LUNCH

12:50-1:40 p.m. ET 112(f)-New Form Paragraphs

• Marjorie Moran, QAS TC1600, USPTO

1:40- 2:40 p.m. ET Requirements for Information Under 37 CFR 1.105 and Responses to Said Requirements

• Amjad Abraham, SPE
• Shubo (Joe) Zhou, SPE TC1600, USPTO

2:40-3 p.m. ET BREAK

3-3:50 p.m. ET Accidental Infringement: the need for additional limitations in plant utility claims directed to chemical profiles or cultivars

• Reggie Gaudino, Chief Science Officer, Steep Hill Labs, Inc.

3:50- 4 p.m. ET Closing Remarks

• Directors, TC1600, USPTO